Daily Newsletter

01 September 2023

Daily Newsletter

01 September 2023

India’s JJ Hospital construction receives 18-month extension

The new completion deadline for the ten-storey building is set for 30 March 2025.

September 01 2023

The deadline for completing construction of the super-speciality building at JJ Hospital in Mumbai, Maharashtra, India, has been extended by 18 months after missing the original July schedule, reported Hindustan Times.

This extension was granted by the new medical education minister Hasan Mushrif to prevent further deferrals that could arise from selecting a new contractor.

The contractor was fined for the delay as well as received a show cause notice.

The official work order for the project was passed in July 2020, with the work originally expected to be completed in around three years.

Currently, the construction work is 29% finished, with the foundation and initial construction challenges mostly overcome.

The new completion deadline for the ten-storey building is set for 30 March 2025.

Following the completion, the project will increase the hospital's capacity by adding 1,200 beds and various specialised units, including cardiovascular, neurosurgery, paediatric, urology, and gastroenterology among others along with a VVIP ward.

The Rs7.78bn ($94.17m) facility will be the largest hospital in Mumbai upon completion.

A senior official from the medical education department was quoted as saying by the publication: “Although the deadline was missed, the reasons given by the contractor were genuine, which were taken into consideration, while giving the extension.

“During the Covid-19 pandemic, work never stopped, though the pace was slow.”

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close